SPDR S&P Pharmaceuticals ETF
Price through Nov 16, 2026 · Flows through Nov 13, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Nov 16, 2026. Holdings snapshot retrieved Nov 16, 2026.
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
XPH price
Table
| Date | XPH close |
|---|---|
| Aug 17, 2026 | $70.42 |
| Aug 18, 2026 | $72.45 |
| Aug 19, 2026 | $74.06 |
| Aug 20, 2026 | $72.29 |
| Aug 21, 2026 | $72.80 |
| Aug 24, 2026 | $72.68 |
| Aug 25, 2026 | $73.57 |
| Aug 26, 2026 | $72.81 |
| Aug 27, 2026 | $72.41 |
| Aug 28, 2026 | $70.79 |
| Aug 31, 2026 | $70.62 |
| Sep 1, 2026 | $70.10 |
| Sep 2, 2026 | $71.47 |
| Sep 3, 2026 | $71.03 |
| Sep 4, 2026 | $70.93 |
| Sep 8, 2026 | $70.38 |
| Sep 9, 2026 | $69.32 |
| Sep 10, 2026 | $68.01 |
| Sep 11, 2026 | $67.51 |
| Sep 14, 2026 | $67.90 |
| Sep 15, 2026 | $66.79 |
| Sep 16, 2026 | $66.79 |
| Sep 17, 2026 | $67.75 |
| Sep 18, 2026 | $66.94 |
| Sep 21, 2026 | $67.52 |
| Sep 22, 2026 | $68.78 |
| Sep 23, 2026 | $66.23 |
| Sep 24, 2026 | $66.40 |
| Sep 25, 2026 | $66.09 |
| Sep 28, 2026 | $66.89 |
| Sep 29, 2026 | $66.09 |
| Sep 30, 2026 | $65.00 |
| Oct 1, 2026 | $63.78 |
| Oct 2, 2026 | $63.64 |
| Oct 5, 2026 | $63.66 |
| Oct 6, 2026 | $62.91 |
| Oct 7, 2026 | $62.91 |
| Oct 8, 2026 | $63.63 |
| Oct 9, 2026 | $64.65 |
| Oct 12, 2026 | $64.01 |
| Oct 13, 2026 | $62.10 |
| Oct 14, 2026 | $62.07 |
| Oct 15, 2026 | $63.02 |
| Oct 16, 2026 | $61.84 |
| Oct 19, 2026 | $62.24 |
| Oct 20, 2026 | $64.15 |
| Oct 21, 2026 | $63.96 |
| Oct 22, 2026 | $64.28 |
| Oct 23, 2026 | $62.70 |
| Oct 26, 2026 | $62.90 |
| Oct 27, 2026 | $63.96 |
| Oct 28, 2026 | $64.55 |
| Oct 29, 2026 | $65.18 |
| Oct 30, 2026 | $64.80 |
| Nov 2, 2026 | $63.61 |
| Nov 3, 2026 | $64.30 |
| Nov 4, 2026 | $65.36 |
| Nov 5, 2026 | $62.65 |
| Nov 6, 2026 | $64.75 |
| Nov 9, 2026 | $67.37 |
| Nov 10, 2026 | $67.93 |
| Nov 11, 2026 | $68.82 |
| Nov 12, 2026 | $67.02 |
| Nov 13, 2026 | $66.83 |
| Nov 16, 2026 | $65.36 |
Weekly net flows, 3M
Net inflow over the range: +$39M
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Aug 10 | $7M |
| Aug 17 | $29M |
| Aug 24 | $10.9M |
| Aug 31 | $42.3M |
| Sep 7 | $27.3K |
| Sep 14 | −$10.1M |
| Sep 21 | −$20.2M |
| Sep 28 | −$38.8M |
| Oct 5 | −$25.2M |
| Oct 12 | −$6.3M |
| Oct 19 | −$9.4M |
| Oct 26 | $9.7M |
| Nov 2 | $12.9M |
| Nov 9 | $37.3M |
Money keeps arriving — +$50M of net inflows over the past month, about 9.6% of the fund's asset base, while the price has returned +16.7% so far this year. At 0.35% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | XERSXERIS BIOPHARMA HOLDINGS | 4.27% | $16.70 | +0.2% | ||
| 2 | MANEVERADERMICS INC | 2.69% | $128.05 | -1.2% | ||
| 3 | LLYELI LILLY | 2.51% | $1431.67 | -0.8% | ||
| 4 | PCRXPACIRA BIOSCIENCES | 2.52% | $36.48 | +0.1% | ||
| 5 | VTRSVIATRIS | 2.48% | $20.74 | -0.4% | ||
| 6 | AMRXAMNEAL PHARMACEUTICALS | 2.49% | $21.23 | -0.7% | ||
| 7 | MAZEMaze Therapeutics | 2.58% | $33.90 | -1.3% | ||
| 8 | ZTSZOETIS | 2.24% | $84.39 | +0.7% | ||
| 9 | RPRXROYALTY PHARMA | 2.25% | $68.53 | -1.1% | ||
| 10 | PRGOPERRIGO CO | 2.23% | $16.18 | -0.4% | ||
| 11 | ELANELANCO ANIMAL HEALTH | 2.23% | $26.41 | -1.4% | ||
| 12 | ETONETON PHARMACEUTICALS | 2.07% | $63.88 | -0.1% | ||
| 13 | COLLCOLLEGIUM PHARMACEUTICAL | 2.06% | $25.43 | +0.4% | ||
| 14 | JNJJOHNSON & JOHNSON | 2.10% | $282.55 | -1.1% | ||
| 15 | LGNDLIGAND PHARMACEUTICALS | 2.17% | $301.71 | -2.3% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 61Sector weights
- Healthcare100%
- Health Technology99.68%
- Other0.33%
- Mutual fund0.32%
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 100% |
| Health Technology | 99.68% |
| Other | 0.33% |
| Mutual fund | 0.32% |
Country weights
- United States100%
- Ireland9.31%
- Singapore0.4%
- Cayman Islands0.39%
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 9.31% |
| Singapore | 0.4% |
| Cayman Islands | 0.39% |
| 1 week | -3.8% |
| 1 month | +5.7% |
| 3 months | -7.9% |
| 6 months | +15.0% |
| YTD | +16.7% |
| 1 year | — |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
| 1 week | +$37M |
| 1 month | +$50M |
| 3 months | +$32M |
| YTD | +$245M |
| 1 year | +$263M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Show as table
| Label | Value ($) |
|---|---|
| Dec | $15.3M |
| Jan | $61.5M |
| Feb | $28.5M |
| Mar | −$71.4K |
| Apr | $25.3M |
| May | −$5.5M |
| Jun | $27.3M |
| Jul | $51.5M |
| Aug | $78.6M |
| Sep | −$15.3M |
| Oct | −$56.9M |
| Nov | $50.2M |
The top holding is 4.3% of the book; the top ten carry 26%. Spread across 60+ names, it behaves like roughly 51 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LLY ELI LILLY | $43M | $45M |
| JNJ JOHNSON & JOHNSON | $6M | $7M |
| MRK MERCK & CO | $6M | $5M |
| BMY BRISTOL MYERS SQUIBB | $2M | $2M |
| LQDA LIQUIDIA | $1M | $2M |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
Due diligence cuts both ways. These funds sit on the same shelf and beat XPH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $41.6B | +$917M | -32bp on fee · 79× the assets · +$917M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -32bp on fee · 35× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.7B | +$109M | -30bp on fee · 234× the assets · +$109M in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $34B | +$587M | -31bp on fee · 64× the assets · +$587M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$422M | -31bp on fee · 45× the assets · +$422M in over the month | Head-to-head |